Clinical trials: Psoriasis Patients
Psoriasis
A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis
The purpose of this study is to evaluate the efficacy and safety of mirikizumab in participants with moderate to severe plaque psoriasis.
- Trial name
- OASIS-1 (NCT03482011)
- Testing
- Mirikizumab
- Where
- 69 sites in United States, Germany and 7 more
- Volunteers
- 530 people
- Sponsor
- Eli Lilly and Company
Psoriasis
A Study of LY3471851 in Participants With Psoriasis
The main purpose of this study is to learn more about the safety of LY3471851 when given by injection just under the skin to participants with psoriasis.
- Trial name
- NCT04119557
- Testing
- LY3471851
- Where
- 24 sites in United States
- Volunteers
- 30 people
- Sponsor
- Nektar Therapeutics
Active Plaque Psoriasis
Study to Assess VB-201 in Patients With Psoriasis
The purpose of this study is to examine the efficacy, safety and tolerability of VB-201 as compared with placebo on measures of disease activity in patients with psoriasis.
- Trial name
- NCT01001468
- Testing
- VB-201
- Where
- 18 sites in United States, Germany and 1 more
- Volunteers
- 185 people
- Sponsor
- Vascular Biogenics Ltd. operating as VBL Therapeutics
Plaque Psoriasis Patients
An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria
With the new reimbursement criteria, we want: To describe the average treatment duration of patients with Enbrel expressed as a number of weeks/year.
- Trial name
- BEFLEX (NCT01557283)
- Testing
- Enbrel treatment
- Where
- Belgium
- Volunteers
- 140 people
- Sponsor
- Pfizer
Psoriasis
Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Psoriasis
This PMCF study is to obtain patient feedback using online questionnaires. There will be no involvement from healthcare professionals (HCPs) or investigator sites.
- Trial name
- NCT07817394
- Testing
- Doublebase Once
- Volunteers
- 100 people
- Sponsor
- Dermal Laboratories Ltd
Psoriasis, Arthritis
Safety and Efficacy of BFH772 in Psoriasis Patients
This study will determine the efficacy of topical BFH772 in psoriasis patients and the safety after multiple dosing.
- Trial name
- NCT00987870
- Testing
- BFH772, calcipotriol/betamethasone
- Where
- Germany
- Volunteers
- 15 people
- Sponsor
- Novartis Pharmaceuticals
Scalp Psoriasis
Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis
A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Design, Multiple-Site, Phase III Clinical Study to Evaluate the Efficacy and Safety of DSXS topical product in Patients with Mild to Severe Scalp Psoriasis
- Trial name
- NCT02933866
- Testing
- DSXS topical, Vehicle topical
- Where
- United States
- Volunteers
- 371 people, healthy volunteers welcome
- Sponsor
- Sun Pharmaceutical Industries, Inc.